Advanz Pharma Corp Equity 2024

Advanz Pharma Corp Aktienanalyse

What does Advanz Pharma Corp do?

Advanz Pharma Corp Ltd is an international pharmaceutical company that focuses on the development, manufacturing, and marketing of generics and specialty pharmaceuticals. The company is headquartered in London and operates numerous subsidiaries worldwide. Answer: Advanz Pharma Corp Ltd is an international pharmaceutical company that specializes in developing, manufacturing, and marketing generics and specialty pharmaceuticals. It was founded in 2015 through the merger of two well-known generic drug manufacturers: Canadian company Concordia International Corp and Irish company Warner Chilcott plc. Advanz Pharma is listed on the Bombay Stock Exchange and the National Stock Exchange of India since 2017. Answer: Advanz Pharma has its own business model that emphasizes the marketing and development of generics and specialty pharmaceuticals. The company focuses on providing cost-effective medical solutions by producing generic versions of products whose patent has expired or is about to expire. These medications are typically more affordable than their original counterparts. However, the company also manufactures specialty pharmaceuticals that specialize in rare diseases, oncology, and hormonal disorders. Answer: Advanz Pharma is divided into several divisions to produce various types of medications, such as: - Cardiology - Oncology - Gastroenterology - Neurology - Antibiotics - Diabetic care - Endocrinology and reproduction Answer: Advanz Pharma manufactures a wide range of generics and specialty pharmaceuticals. Some of the products include: - Metformin, an antidiabetic medication - Carbidopa/levodopa, a medication for treating Parkinson's disease - Ezetimibe, for lowering cholesterol levels - Doxorubicin, a cancer medication - Hydroxyzine, an antiallergic medication - Methotrexate, a cancer and rheumatoid arthritis medication Answer: In conclusion, Advanz Pharma Corp Ltd is an international generics and specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of cost-effective medications. The company has a broad product portfolio that includes both generics and specialized medications. It aims to provide cost-effective solutions to improve access to essential healthcare. Advanz Pharma Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Advanz Pharma Corp's Equity

Advanz Pharma Corp's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Advanz Pharma Corp's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Advanz Pharma Corp's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Advanz Pharma Corp's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Advanz Pharma Corp’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Advanz Pharma Corp stock

What is the equity of Advanz Pharma Corp this year?

Advanz Pharma Corp has equity of 0 USD this year.

What was the equity of Advanz Pharma Corp compared to the previous year?

The equity of Advanz Pharma Corp has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Advanz Pharma Corp?

A high equity is advantageous for investors of Advanz Pharma Corp as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Advanz Pharma Corp?

A low equity can be a risk for investors of Advanz Pharma Corp, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Advanz Pharma Corp affect the company?

An increase in equity of Advanz Pharma Corp can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Advanz Pharma Corp affect the company?

A reduction in equity of Advanz Pharma Corp can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Advanz Pharma Corp?

Some factors that can affect the equity of Advanz Pharma Corp include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Advanz Pharma Corp so important for investors?

The equity of Advanz Pharma Corp is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Advanz Pharma Corp take to change the equity?

To change equity, Advanz Pharma Corp can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Advanz Pharma Corp pay?

Over the past 12 months, Advanz Pharma Corp paid a dividend of 67.5 USD . This corresponds to a dividend yield of about 395.66 %. For the coming 12 months, Advanz Pharma Corp is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanz Pharma Corp?

The current dividend yield of Advanz Pharma Corp is 395.66 %.

When does Advanz Pharma Corp pay dividends?

Advanz Pharma Corp pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Advanz Pharma Corp?

Advanz Pharma Corp paid dividends every year for the past 0 years.

What is the dividend of Advanz Pharma Corp?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanz Pharma Corp located?

Advanz Pharma Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanz Pharma Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanz Pharma Corp from 7/29/2016 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2016.

When did Advanz Pharma Corp pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Advanz Pharma Corp in the year 2023?

In the year 2023, Advanz Pharma Corp distributed 0 USD as dividends.

In which currency does Advanz Pharma Corp pay out the dividend?

The dividends of Advanz Pharma Corp are distributed in USD.